Akut Poststreptokoksik Glomerülonefrite Bağlı Gelişen Hızlı İlerleyici Glomerülonefrit
Akut poststreptokoksik glomerülonefrit prognozu oldukça iyi bir hastalıktır. Hızlı ilerleyen glomerülonefrit, postinfeksiyöz glomerülonefritin ender bir şeklidir. Akut nefritik sendrom olarak tanımlanan ve hızla ilerleyen, birkaç ay içinde böbrek fonksiyon kaybı olan hızlı progresif glomerülonefrit tanısı patolojide %50’nin üstünde kresent oluşumuyla konur. Hızlı ilerleyen glomerülonefritte böbrek fonksiyonlarını korumak için erken teşhis ve tedavi önemlidir. Erken teşhis ve tedavi edilen bu hastalar genel olarak iyi bir klinik prognoza sahiptir. Vakamız 11 yaşında cilt enfeksiyonu sonrası glomerülonefrit tablosuyla gelen erkek hastadır. Böbrek biyopsisiyle hızlı ilerleyen glomerülonefrit tanısı almıştır. Akut poststreptokoksik glomerülonefritte hızlı ilerleyen glomerülonefrit gelişiminin ender olması ve tedaviler sonrası iyi prognozlu seyretmesi nedeniyle sunulmuştur
Rapidly Progressive Glomerulonephritis Developed Due to Acute Poststreptococcal Glomerulonephritis
The eventual outcome of acute poststreptococcal glomerulonephiritis is quite benign in most cases. Rapidly progressive glomerulonephritis is a rare form of postinfectious glomerulonephritis. Rapidly progressive glomerulonephritis defined as acute nephritic syndrome with dramatic loss of renal function within a few months, is diagnosed histopathologically with the presence of crescents in ≥50% of the samples. This patient achieving a good clinical prognosis overall. Early diagnosis and treatment of rapidly progressive glomerulonephritis is important to preserve renal function, which is a key factor for achieving a good prognosis. Our case is a 11-year-old male who presented with glomerulonephritis after onset of skin infection. He was diagnosed as crescentic glomerulonephritis in kidney biopsy. This case has been reported because rapidly progressive glomerulonephritis developing after acute poststreptoccoccal glomerulonephiritis is rare and has a good prognosis after treatment
___
- Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Stuart L. Goldstein pediatric nephrology seventh edition 2016;959-83.
- Kidney disease improving global outcomes (KDIGO) glomerulonephritis work group. Clinical Practice Guideline for Glomerulonephritis. Kidney Int. 2012; 2 suppl:39-274.
- Piyaphanee N, Supavekin S, Sumboonnanonda A. Renal outcome and risk factors for end-stage renal disease in pediatric rapidly progressive glomerulo- nephritis. Pediatrics International 2017;59:334-41. https://doi.org/10.1111/ped.13140
- Arimura Y, Muso E, Fujimoto S, Hasegawa M, Kaname S, Usui J, et al. Evidence-based clinical practice guideli- nes for rapidly progressive glomerulonephritis 2014 Clin Exp Nephrol. 2016;20:322-41. https://doi.org/10.1007/s10157-015-1218-8
- Kanai H, Sawanobori E, Koizumi K, Ohashi R, Higashida K. Pediatric case of crescentic post-streptococcal glo- merulonephritis with myeloperoxidase anti-neutrophil cytoplasmic 2015;83:243-8. Clinical Nephrology
- Madeleine W. Cunningham. Pathogenesis of Group A streptococcal infections. Clinical Microbiology Reviews; 2000;13:470-511. https://doi.org/10.1128/CMR.13.3.470
- Vehaskari VM, Aviles DH. Acute glomerulonephritis and rapidly progressive glomerulonephritis. In: Kher KK, Schnaper HW, Makker SP, eds. Clinical Pediatric Nephrology. 2nd ed. Abingdon, Oxon: Informa Healthcare; 2007:145-54.
- Bitzan M. Glomerular Diseases / Acute Glomerulonephritis. In: Phadke K, Goodyer P, Bitzan M, eds. Manual of Pediatric Nephrology. New York Dordrecht London: Springer-Verlag Berlin Heidelberg; 2014:141-2. https://doi.org/10.1007/978-3-642-12483-9_3